These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 7851055)
21. [Theoretical research for therapy of infection]. Shimizu K Nihon Sanka Fujinka Gakkai Zasshi; 1991 Aug; 43(8):815-23. PubMed ID: 1655924 [TBL] [Abstract][Full Text] [Related]
22. In vivo postantibiotic effect in a thigh infection in neutropenic mice. Vogelman B; Gudmundsson S; Turnidge J; Leggett J; Craig WA J Infect Dis; 1988 Feb; 157(2):287-98. PubMed ID: 3121761 [TBL] [Abstract][Full Text] [Related]
23. Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time. Hanberger H Scand J Infect Dis Suppl; 1992; 81():1-52. PubMed ID: 1322561 [TBL] [Abstract][Full Text] [Related]
24. The pharmacodynamics of aminoglycosides. Lacy MK; Nicolau DP; Nightingale CH; Quintiliani R Clin Infect Dis; 1998 Jul; 27(1):23-7. PubMed ID: 9675444 [TBL] [Abstract][Full Text] [Related]
25. Postantibiotic effect of a combination of antimicrobial agents on pseudomonas aeruginosa. Sood P; Mandal A; Mishra B Chemotherapy; 2000; 46(3):173-6. PubMed ID: 10765031 [TBL] [Abstract][Full Text] [Related]
26. Impact of pharmacokinetics on the postantibiotic effect exhibited by Pseudomonas aeruginosa following tobramycin exposure: application of an in-vitro model. Zhu ZY; Li RC J Antimicrob Chemother; 1998 Jul; 42(1):61-5. PubMed ID: 9700529 [TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones. Dudley MN Am J Med; 1991 Dec; 91(6A):45S-50S. PubMed ID: 1767806 [TBL] [Abstract][Full Text] [Related]
33. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955 [TBL] [Abstract][Full Text] [Related]
35. Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. Craig WA J Antimicrob Chemother; 1993 May; 31 Suppl D():149-58. PubMed ID: 8335516 [TBL] [Abstract][Full Text] [Related]
36. Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens. McCormack JP; Schentag JJ Drug Intell Clin Pharm; 1987 Feb; 21(2):187-92. PubMed ID: 3829911 [TBL] [Abstract][Full Text] [Related]
37. In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin. Novelli A; Mazzei T; Fallani S; Cassetta MI; Conti S J Chemother; 1995 Aug; 7(4):355-62. PubMed ID: 8568546 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755 [TBL] [Abstract][Full Text] [Related]
40. [Studies of dosing regimens and combination effects of aminoglycosides and beta-lactam in an experimental Pseudomonas aeruginosa infection in mice]. Kikuchi K Kansenshogaku Zasshi; 1991 Feb; 65(2):216-25. PubMed ID: 2066605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]